Position in CRVS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$174,843
+$89,040 QoQ
Shares Held
11,951
-25.5% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Virtu Financial LLC holds $37,861,226 across 147 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
58,459 | $4,130,128 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
29,790 | $3,954,026 | |
| 3 | ABVX |
Abivax S.A.
|
19,155 | $2,552,595 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
9,220 | $2,256,779 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
12,556 | $1,439,796 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
8,163 | $1,000,620 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
17,524 | $962,768 | |
| 8 | IOVA |
Iovance Biotherapeutics, Inc.
|
221,500 | $921,440 |
All Filings in CRVS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $174,843 | 11,951 | Shares | Defined | 2026-05-14 | |
| 2024-12-31 | $85,803 | 16,038 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $82,864 | 15,694 | Shares | Defined | 2024-11-20 | |
| 2024-03-31 | $22,374 | 12,570 | Shares | Defined | 2024-05-20 | |
| 2023-09-30 | $25,354 | 17,366 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $58,491 | 25,542 | Shares | Defined | 2023-07-27 | |
| 2023-03-31 | $17,612 | 19,354 | Shares | Defined | 2023-05-01 | |
| 2022-12-31 | $15,944 | 18,758 | Shares | Defined | 2023-02-15 | |
| 2022-03-31 | $23,401 | 14,269 | Shares | Defined | 2022-05-17 | |
| 2021-09-30 | $95,289 | 19,688 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||